Advertisement
Advertisement
October 16, 2011
St. Jude Medical Conducts Feasibility Study of Renal Denervation Technology
October 17, 2011—St. Jude Medical, Inc. (St. Paul, MN) announced the commencement of a feasibility study of the company's renal denervation catheter and generator system. The technology was developed as a treatment for resistant hypertension. Prof. Stephen Worthley, MB, BS, PhD, performed the study's first procedure, which marked the initial use of the technology. St. Jude Medical expects a limited market launch in Europe before the end of 2012.
Prof. Worthley commented, “The design of this catheter minimizes the need for extensive catheter manipulation, which could potentially shorten procedure time, limit contrast use, and reduce fluoroscopic exposure for me, my patients, and other cath lab staff.”
Advertisement
Advertisement
